Longitudinal Surveillance Study: Impact of Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study – The Lancet (free)

Commentaries: Population versus individual protection by pneumococcal conjugate vaccination – The Lancet (free) AND PCV10 pneumococcal vaccine has big impact in Kenya, even among unvaccinated individuals – Johns Hopkins University Bloomberg School of Public Health (free)

Related Commentary on Twitter

Introduction of 10-valent #pneumococcal conjugate vaccine in Kenya, accompanied by a catch-up campaign, substantially reduced invasive pneumococcal disease in children & adults without significant replacement disease: a longitudinal surveillance study https://t.co/pOm7kR2JbQ pic.twitter.com/E1wt2p1waE

— The Lancet (@TheLancet) April 15, 2019